At blood sampling | HC (n = 50) | PsC (n = 200) | pPsA (n = 127) | PsSpA (n = 117) | AS (n = 157) |
---|---|---|---|---|---|
Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | |
Age (years) | 59.93 (51.44, 67.56) | 54 (42, 65) | 58.45 (50.31, 66.63) | 59.53 (59.56, 66.54) | 54.70 (44.52, 63.41) |
Disease duration (years) | n/a | 24 (16, 36.5) | 15 (7, 26) | 18 (9, 27) | 22 (10, 31) |
BMI (kg/m2) | n/a | n/a | 29.04 (26.30, 32.84) | 28.56 (26.06, 31.98) | 27.07 (24.58, 30.13) |
CRP (mg/dL) | n/a | n/a | 2 (0, 5) | 3 (2, 7) | 4 (1, 10) |
ASDAS (units) | n/a | n/a | 2.1 (1.3, 2.7) | 2.2 (1.5, 2.9) | 2.1 (1.6, 2.9) |
PASI (units) | n/a | 4.8 (2.4, 8.8) | 0.8 (0.0, 2.6) | 0.8 (0.0, 2.8) | n/a |
 | n (%) | n (%) | n (%) | n (%) | n (%) |
Male sex | 26 (52.00) | 102 (51.00) | 66 (51.97) | 74 (63.25) | 118 (75.16) |
Anti-TNF use | n/a | 26 (13.00) | 47 (37.01) | 53 (45.30) | 59 (37.58) |
HLA-B27 positive | n/a | n/a | 9 (7.09) | 47 (40.17) | 140 (89.17) |